MG
Meditor Group Portfolio holdings
AUM
$48.1M
This Quarter Return
-4.47%
1 Year Return
+38.67%
3 Year Return
+41.15%
5 Year Return
+72.2%
10 Year Return
+1,065.64%
AUM
$497M
AUM Growth
+$497M
(-6.8%)
Cap. Flow
-$9.51M
Cap. Flow
% of AUM
-1.91%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
2
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ProShares UltraPro Short QQQ
SQQQ
|
$7.51M |
| 2 |
Exelixis
EXEL
|
$2M |
Sector Composition
| 1 | Healthcare | 93.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Exelixis
EXEL
$10.1B
| $321M | 64.48% | 15,001,073 -93,422 | -0.6% | -$2M |
|
2
Esperion Therapeutics
ESPR
$448M
| $125M | 25.08% | 2,679,835 | – | – |
|
3
Alkermes
ALKS
$4.78B
| $20.1M | 4.05% | 892,400 | – | – |
|
4
iShares MSCI India ETF
INDA
$9.17B
| $11.3M | 2.27% | 320,000 | – | – |
|
5
WisdomTree India Earnings Fund ETF
EPI
$2.86B
| $10.4M | 2.1% | 400,000 | – | – |
|
6
ProShares UltraShort S&P500
SDS
$445M
| $3.53M | 0.71% | 115,000 | – | – |
|
7
ProShares UltraPro Short S&P 500
SPXU
$527M
| $2.92M | 0.59% | 105,000 | – | – |
|
|
8
ProShares UltraPro Short QQQ
SQQQ
$2.39B
| $2.5M | 0.5% | 71,250 -213,750 | -75% | -$7.51M |
|
9
Celldex Therapeutics
CLDX
$1.47B
| $1.13M | 0.23% | 420,846 | – | – |
|